The Best for the Individual – the Essentials for All
-
Erwin-Schrödinger-Saal
Plenary
/
German and English languageDeciphering the genetic code is a significant milestone on the road towards individualised and personalised health care. It is a big challenge to render this process accessible for society as a whole. Which strategies will actually lead to better health and wellbeing?
| |||||
| |||||
| |||||
|
Heather DEWEY-HAGBORG
Artist; Assistant Professor of Art and Technology Studies, School of the Art Institute, Chicago
MD. Ph.D. Leroy HOOD
President and Co-Founder, Institute for Systems Biology, Seattle
| 1963-1964 | NIH Predoctoral Fellowship, California Institute of Technology |
| 1964-1967 | NIH Postdoctoral Fellowship, California Institute of Technology |
| 1967-1970 | Senior Investigator, Immunology Branch, GL&C, NCI, NIH, Bethesda, MD |
| 1970-1973 | Assistant Professor of Biology, California Institute of Technology |
| 1973-1975 | Associate Professor of Biology, California Institute of Technology |
| 1975-1977 | Professor of Biology, California Institute of Technology |
| 1977-1992 | Bowles Professor of Biology, California Institute of Technology |
| 1980-1989 | Chairman, Division of Biology, California Institute of Technology |
| 1981-1992 | Director, Cancer Center, California Institute of Technology |
| 1992-1999 | William Gates III Professor & Chairman, Department of Molecular Biotechnology, School of Medicine, University of Washington |
| 1989-2000 | Director, NSF Science & Technology Center for Molecular Biotechnology, Caltech |
| since 1992 | Affiliate Professor, Departments of Bioengineering, Computer Science & Immunology |
| President and Professor, Institute for Systems Biology, Seattle, WA |
Ph. D. Calum MACKELLAR
Director of Research, The Scottish Council on Human Bioethics Ltd., Edinburgh
| 1991-1992 | Postdoctoral Research Fellowship studying the synthesis and applications of genetic antivirals as potent drugs against AIDS/HIV, University of Edinburgh and the Medical Research Council |
| 1993-1997 | Associate, Synthesis of New Kinds of Drugs for Gene-Therapy, Link Technologies Ltd, Glasgow Research and Development |
| 1997-2001 | Visiting/Associate Lecturer in Biological Chemistry and Bioethics, Queen Margaret University, Edinburgh |
| 2001-2003 | Senior Civil Servant, Bioethics Division in the Directorate General of Legal Affairs, Council of Europe Strasbourg |
| since 2003 | Director of Research, Scottish Council on Human Bioethics, Scottish Charity, Edinburgh |
| since 2010 | Visiting Lecturer & Visiting Professor of Bioethic, St Mary s University, Twickenham, London |
Emilio GALLI-ZUGARO
Chairman, Methodos S.p.A., Milan; Founder, Orvieto Academy for Communicative Leadership, Munich/Orvieto
| Studied Political Sciences in Würzburg and Rome | |
| 1980-1985 | Communcation functions in public service, Rome |
| 1985-1992 | Journalist for FORTUNE, Wirtschaftswoche, L'Independente, Italia Oggi, Il Giornale, Finanz und Wirtschaft, The European |
| since 1996 | Author and Scholar, Ludwig-Maximilians-University, Munich |
| since 2000 | European School of Management and Technology, Berlin |
| 1992-2015 | Head of Group Communications, Allianz SE, Munich |
| since 2015 | Chairman of Methodos, S.p.A., Milan |
| Executive coach and mentor, Entrepreneurship Center, Munich | |
| since 2017 | Founder, Orvieto Academy for Communicative Leadership, Orvieto |
Update Required
To play the media you will need to either update your browser to a recent version or update your Flash plugin.
